多重耐药
流出
抗生素耐药性
抗药性
抗生素
微生物学
医学
重症监护医学
生物
生物技术
纳米技术
材料科学
遗传学
作者
Xiaolei Xu,Xu-Qi Kang,Jing Qi,Jian Fan,Di Liu,Yongzhong Du
标识
DOI:10.2174/1381612825666191022163237
摘要
Background: Antibacterial multidrug resistance has emerged as one of the foremost global problems affecting human health. The emergence of resistant infections with the increasing number of multidrug-resistant pathogens has posed a serious problem, which required innovative collaborations across multiple disciplines to address this issue. Methods: In this review, we will explain the mechanisms of bacterial multidrug resistance and discuss different strategies for combating it, including combination therapy, the use of novel natural antibiotics, and the use of nanotechnology in the development of efflux pump inhibitors. Results: While combination therapy will remain the mainstay of bacterial multi-drug resistance treatment, nanotechnology will play critical roles in the development of novel treatments in the coming years. Conclusion: Nanotechnology provides an encouraging platform for the development of clinically relevant and practical strategies to overcome drug resistance in the future.
科研通智能强力驱动
Strongly Powered by AbleSci AI